USP6NL和MSX2作为胃癌患者的新诊断标志物
Zahra Basirat1, Negin Taghehchian1, Mohammad Reza Abbaszadegan1
1Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Cancer treatment and research communications
|August 20, 2025
概括
这项研究显示USP6NL及其WNT通路目标MSX2和C-MYC在胃癌 (GC) 中显著升高,与患者的生存相关. 这个USP6NL/MSX2/C-MYC轴可以作为GC的诊断标记或治疗目标.
科学领域:
- 癌症学
- 分子生物学
- 胃肠病学
背景情况:
- 胃癌是一种常见的胃肠恶性瘤.
- 在GC发生和进展中,WNT信号通路至关重要.
- USP6NL是一种GAP家族蛋白质,通过β-catenin稳定调节WNT信号.
研究的目的:
- 研究USP6NL在胃癌进展中的作用.
- 研究USP6NL对GC患者的WNT信号通路的调节.
- 评估USP6NL与GC中的WNT目标基因MSX2和C-MYC的关系.
主要方法:
- 使用实时聚合酶链反应 (PCR) 来量化mRNA表达水平.
- 在83个新鲜的瘤和正常的胃组织中评估了USP6NL,MSX2和C- MYCmRNA水平.
- 进行统计分析以确定相关性和显著性.
主要成果:
- 与心脏瘤相比,非心脏GC的USP6NL表达显著更高 (p=0. 03).
- 在女性与男性的非心脏瘤中观察到更高的USP6NL表达 (p=0. 032).
- 在GC患者,特别是女性中,MSX2上调与较低的存活率相关 (p=0. 012, p=0. 041).
- USP6NL水平与MSX2 (p≤0.0001) 和C-MYC (p=0.001) 表达有显著的相关性.
结论:
- USP6NL/MSX2/C-MYC轴与胃癌的进展有关.
- 这个轴显示了作为GC可靠的诊断标记的潜力.
- 需要进一步的体外和动物研究来验证USP6NL作为GC的治疗标.
相关概念视频
01:33Peptide Identification Using Tandem Mass Spectrometry
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...